X-108153135-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000372232.8(ATG4A):c.1126+48G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.455 in 906,757 control chromosomes in the GnomAD database, including 71,456 homozygotes. There are 115,420 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.50 ( 10721 hom., 15884 hem., cov: 23)
Exomes 𝑓: 0.45 ( 60735 hom. 99536 hem. )
Consequence
ATG4A
ENST00000372232.8 intron
ENST00000372232.8 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.441
Genes affected
ATG4A (HGNC:16489): (autophagy related 4A cysteine peptidase) Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly. Autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels of autophagy have been described in some malignant tumors, and a role for autophagy in controlling the unregulated cell growth linked to cancer has been proposed. This gene encodes a member of the autophagin protein family. The encoded protein is also designated as a member of the C-54 family of cysteine proteases. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant X-108153135-G-A is Benign according to our data. Variant chrX-108153135-G-A is described in ClinVar as [Benign]. Clinvar id is 2688198.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.672 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATG4A | NM_052936.5 | c.1126+48G>A | intron_variant | ENST00000372232.8 | NP_443168.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATG4A | ENST00000372232.8 | c.1126+48G>A | intron_variant | 1 | NM_052936.5 | ENSP00000361306 | P1 |
Frequencies
GnomAD3 genomes AF: 0.498 AC: 54933AN: 110365Hom.: 10713 Cov.: 23 AF XY: 0.485 AC XY: 15839AN XY: 32639
GnomAD3 genomes
AF:
AC:
54933
AN:
110365
Hom.:
Cov.:
23
AF XY:
AC XY:
15839
AN XY:
32639
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.414 AC: 62245AN: 150306Hom.: 10520 AF XY: 0.417 AC XY: 17849AN XY: 42758
GnomAD3 exomes
AF:
AC:
62245
AN:
150306
Hom.:
AF XY:
AC XY:
17849
AN XY:
42758
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.449 AC: 357206AN: 796335Hom.: 60735 Cov.: 12 AF XY: 0.468 AC XY: 99536AN XY: 212861
GnomAD4 exome
AF:
AC:
357206
AN:
796335
Hom.:
Cov.:
12
AF XY:
AC XY:
99536
AN XY:
212861
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.498 AC: 54983AN: 110422Hom.: 10721 Cov.: 23 AF XY: 0.486 AC XY: 15884AN XY: 32708
GnomAD4 genome
AF:
AC:
54983
AN:
110422
Hom.:
Cov.:
23
AF XY:
AC XY:
15884
AN XY:
32708
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 37% of patients studied by a panel of primary immunodeficiencies. Number of patients: 35. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at